FLORENCE, Italy — At the FLOREtina meeting, Young-Hee Yoon, MD, PhD, gives her views on when to start and how long to continue anti-VEGF treatment for myopic choroidal neovascularization. Based on 5-year follow-up data, Yoon addresses questions that were not resolved in pivotal trials.
D.C. Week: Healthcare.gov Signs Up 8.2 Million
(MedPage Today) — FDA softens decades-old ban on blood donations from men who have sex with men
Misperceptions Drive Pot Use Among Patients With Glaucoma
Patients with glaucoma are more likely to use marijuana for treatment if they believe it is safe and effective, according to a new study. Medscape Medical News
Music therapy in conjunction with standard rehabilitation benefits COPD patients
Patients with Chronic Obstructive Pulmonary Disease (COPD) and other chronic respiratory disorders who received music therapy in conjunction with standard rehabilitation saw an improvement in symptoms, psychological well-being and quality of life compa…
UTA physicists devise gene therapy platform for macular degeneration patients
Millions of adults over age 50 struggle each year with vision loss caused by damage to the retina or common macular degeneration.This is a photograph of a laser gene delivery system.
Recent discovery leads to PDEK as another cornea transplant option
According to an Eye Bank Association of America statistical report, which includes data from 76 U.S. member eye banks, just under 48,000 keratoplasty procedures were performed domestically in 2014. This number has been relatively flat for several years, but the type of transplant continues to evolve significantly.The top four indications for keratoplasty in the U.S. are Fuchs’ dystrophy (21.5%), post-cataract surgery corneal edema (12.2%), keratoconus (10.1%) and graft failure (9.9%).